AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hims & Hers Health Surges to 17th in Trading Volume with $39.99 Billion in Shares Exchanged Amid Lawsuit Controversy
Generated by AI AgentAinvest Volume Radar
Friday, Jun 27, 2025 8:01 pm ET1min read
On June 27, 2025,
(HIMS) saw a significant surge in trading volume, with a total of $39.99 billion in shares exchanged, marking a 39.34% increase from the previous day. This surge placed & Hers Health at the 17th position in terms of trading volume for the day. The stock price of Hims & Hers Health also rose by 6.81%, marking the second consecutive day of gains and a total increase of 19.37% over the past two days.Hims & Hers Health is currently facing multiple securities class action lawsuits. These lawsuits allege that the company made false statements and concealed information regarding its collaboration with
. The complaints assert that Hims & Hers was involved in the deceptive promotion and selling of illegitimate, knockoff versions of Wegovy®, a medication manufactured by Novo Nordisk. This alleged misconduct put patient safety at risk and led to the termination of the partnership between Hims & Hers and Novo Nordisk on June 23, 2025.Investors who purchased Hims & Hers securities between April 29, 2025, and June 23, 2025, are encouraged to seek legal advice. The lawsuits allege that the company's top executives violated the Securities Exchange Act of 1934 by making false and misleading statements during this period. The lead plaintiff process allows investors to seek appointment as lead plaintiff in the class action lawsuit, directing the litigation on behalf of all class members.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet